CDSS can be used for a variety of clinical activities such as preventive care, diagnostics, therapeutics, comprehensive disease management, image recognition and interpretation and prognostics. Theoretically, they can be used for any speciality of clinical care and in any setting, where the requisite knowledge base and technological infrastructure exist. The plasticity of this application suggests a diverse range of opportunities that influence the quality and safety of healthcare.
New analysis from Frost & Sullivan (healthcareIT.frost.com), Clinical Decision Support Systems Markets in North America and Europe, finds that the markets earned revenues of $137.5 million in 2009 and estimates this to reach $364.1 million in 2016. The geographic markets covered in this research service include the United Kingdom, Germany, France, Italy, Spain, Scandinavia, Benelux, the United States and Canada.
"Health services need to find new, more cost-effective ways of delivering care due to the serious financial and resource implications of ageing populations, improved survival from a range of acute and long-term disorders, and the ever increasing array of treatment options now available," says Frost & Sullivan Programme Leader Konstantinos Nikolopoulos. "Major national efforts are underway world-wide to promote the widespread and effective use of tools such as the electronic medical record and computerised physician order entry systems."
Although computerising clinical data and transactions can substantially develop information management in patient care, CDSS reaches its full potential only when the relevant clinical knowledge is combined with the data to take informed healthcare decisions and actions. Furthermore, CDSS is proven effective in improving outcomes at several state-of-the-art healthcare institutions by reducing adverse drug events, medication-related errors and costs by millions of dollars per year even within single hospitals. If these results are scaled up to a regional and national level, CDSSs have the potential to save thousands of lives and billions of dollars each year.
However, clinical knowledge and decision support interventions for use in clinical information systems can currently be obtained from a variety of sources whose formats are non-standard and accessibility is variable. These sources include healthcare IT vendor’s shared libraries, commercial decision support content publishers and the Internet. Such non-standardised and independent approaches to create and present clinical knowledge and interventions severely limit incorporation, re-usability and interoperability in clinical information systems.
"The major factor limiting the full adoption and impact of CDSS is the lack of a common and transportable base of clinical knowledge and clinical decision support interventions that can be easily and widely used in electronic health records and other clinical information systems." explains Nikolopoulos. "Further, clinicians sometimes resist the use of CDSS as they fear that these will reduce autonomy or increase liability."
Several organisations do not recognise a clear business case for financial and organisational investments in developing and executing a plan to optimise CDSSs. Vendors of CDSSs should collaborate with policy makers to address these issues.
"Similar to other health care information technologies, the costs associated with CDSS implementation are primarily borne by healthcare organisations while many of the benefits accrue to patients, payers and the society as a whole in terms of improved healthcare," concludes Nikolopoulos. "Supportive policies and new financial incentives will help to redress these deficiencies and facilitate adoption of CDSS tools more swiftly and broadly."
If you are interested in more information on Frost & Sullivan’s study Clinical Decision Support Systems Markets in North America and Europe, please send an email to Katja Feick, Corporate Communications, at katja.feick[.]frost.com with your full name, company name, title, telephone number, company email address, company website, city, state and country.
Clinical Decision Support Systems Markets in North America and Europe is part of the Healthcare & Life Sciences IT Growth Partnership Services programme, which also includes research in the following markets: Pharmacy Information Systems, Digital Pathology Systems, Electronic Medical Records, and Business Analytics Systems. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.
Clinical Decision Support Systems Markets in North America and Europe / M532